An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients

Background. Male breast cancer is rare, and there are no large comparative studies to guide treatment. We used National Cancer Data Base data on 4755 men and 624,174 women who had breast cancer (1985-1994) to identify equivalent groups of male and female breast cancer patients. Methods. For each man with breast canes the next woman treated at the same hospital was sought who matched the man's age (within 5 years), ethnicity, income category, and stage. We identified 3627 closely by matched pairs of male and female patients with breast cancer. Results. Men were more likely to be treated with mastectomy (modified radical, 65% of men versus 55.1% of women; radical, 2.5% of men versus 0.9% of women; simple 7.6% of men versus 3.4% of women; P < .001), and more likely to receive radiation therapy after mastectomy (men, 29%; women, 11%; P < .001). Men treated with lumpectomy were less likely to receive radiation therapy (men, 54%; women, 68%; P < .001). Men were also less likely to receive chemotherapy (26.7% of men versus 40.6% of women; P < .001) after any surgical treatment. Conclusions. This large comparative study is the first to detail stage-specific differences In contemporary treatment strategies or highly comparable groups of men and women treated for breast cancer Further studies of male breast cancer should focus on identifying prognostic factors and defining optimal therapy.